| Lacy Chavis, PSYD | |
|
880 6th St S Ste 420, St Petersburg, FL 33701-4825 | |
| (727) 767-8477 | |
| Not Available |
| Full Name | Lacy Chavis |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 880 6th St S Ste 420, St Petersburg, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093020786 | NPI | - | NPPES |
| WVE061 | Other | NY | AGENCY MEDICARE ID# |
| 1285628552 | Other | NY | AGENCY NPI # |
| 00355940 | Other | NY | AGENCY MEDICAID PROVIDER ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | (New York) | Primary |
| 103T00000X | Psychologist | PY8429 (Florida) | Secondary |
| Entity Name | Florida Health Sciences Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235196510 PECOS PAC ID: 1759277841 Enrollment ID: O20040225000764 |
News Archive
Researchers performed a large-scale, double-blind, placebo-controlled phase two trial to assess the efficacy, safety, and immune response elicited from vaccination with MVC-COV1901.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, and Celera Corporation, one of the world's pioneers in genetic diagnostics discovery and development, announced today that they have entered into a definitive merger agreement under which Quest Diagnostics will acquire Celera for $8 per share, representing a transaction value of approximately $344 million, net of $327 million in acquired cash and short-term investments.
Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal of Medicine and presented at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago.
Dendreon Corporation today reported results for the year and quarter ended December 31, 2011. Product revenue for the year ended December 31, 2011 was $213.5 million compared to $48 million for the year ended December 31, 2010. Product revenue for the fourth quarter of 2011 was $77 million compared to $25 million for the quarter ended December 31, 2010.
New research has shown that children's risk for learning and behavior problems and obesity rises in correlation to their level of trauma exposure, says the psychiatrist at the Stanford University School of Medicine and Lucile Packard Children's Hospital who oversaw the study. The findings could encourage physicians to consider diagnosing post-traumatic stress disorder rather than attention deficit/hyperactivity disorder, which has similar symptoms to PTSD but very different treatment.
› Verified 5 days ago
| Entity Name | Tampa General Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043557853 PECOS PAC ID: 7416253828 Enrollment ID: O20160310002525 |
News Archive
Researchers performed a large-scale, double-blind, placebo-controlled phase two trial to assess the efficacy, safety, and immune response elicited from vaccination with MVC-COV1901.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, and Celera Corporation, one of the world's pioneers in genetic diagnostics discovery and development, announced today that they have entered into a definitive merger agreement under which Quest Diagnostics will acquire Celera for $8 per share, representing a transaction value of approximately $344 million, net of $327 million in acquired cash and short-term investments.
Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal of Medicine and presented at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago.
Dendreon Corporation today reported results for the year and quarter ended December 31, 2011. Product revenue for the year ended December 31, 2011 was $213.5 million compared to $48 million for the year ended December 31, 2010. Product revenue for the fourth quarter of 2011 was $77 million compared to $25 million for the quarter ended December 31, 2010.
New research has shown that children's risk for learning and behavior problems and obesity rises in correlation to their level of trauma exposure, says the psychiatrist at the Stanford University School of Medicine and Lucile Packard Children's Hospital who oversaw the study. The findings could encourage physicians to consider diagnosing post-traumatic stress disorder rather than attention deficit/hyperactivity disorder, which has similar symptoms to PTSD but very different treatment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lacy Chavis, PSYD 880 6th St S Ste 420, St Petersburg, FL 33701-4825 Ph: (727) 767-8477 | Lacy Chavis, PSYD 880 6th St S Ste 420, St Petersburg, FL 33701-4825 Ph: (727) 767-8477 |
News Archive
Researchers performed a large-scale, double-blind, placebo-controlled phase two trial to assess the efficacy, safety, and immune response elicited from vaccination with MVC-COV1901.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, and Celera Corporation, one of the world's pioneers in genetic diagnostics discovery and development, announced today that they have entered into a definitive merger agreement under which Quest Diagnostics will acquire Celera for $8 per share, representing a transaction value of approximately $344 million, net of $327 million in acquired cash and short-term investments.
Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal of Medicine and presented at the 2015 Annual Meeting of the American Society of Clinical Oncology in Chicago.
Dendreon Corporation today reported results for the year and quarter ended December 31, 2011. Product revenue for the year ended December 31, 2011 was $213.5 million compared to $48 million for the year ended December 31, 2010. Product revenue for the fourth quarter of 2011 was $77 million compared to $25 million for the quarter ended December 31, 2010.
New research has shown that children's risk for learning and behavior problems and obesity rises in correlation to their level of trauma exposure, says the psychiatrist at the Stanford University School of Medicine and Lucile Packard Children's Hospital who oversaw the study. The findings could encourage physicians to consider diagnosing post-traumatic stress disorder rather than attention deficit/hyperactivity disorder, which has similar symptoms to PTSD but very different treatment.
› Verified 5 days ago
William Frye, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 880 6th St S Ste 430, St Petersburg, FL 33701 Phone: 727-767-8477 Fax: 727-767-8244 | |
Dr. Erin L Witek, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6740 Crosswinds Dr N Unit L, St Petersburg, FL 33710 Phone: 727-599-3624 | |
Sara Elizabeth Leslie, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 735 Arlington Ave N, Ste 212, St Petersburg, FL 33701 Phone: 727-831-1723 | |
Miss Betty Horng, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 800 6th St S, Childrens Health Center, St Petersburg, FL 33701 Phone: 727-767-4150 Fax: 727-767-8532 | |
Dr. Laura Kristine Bonnemort, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 9887 4th St N Ste 319, St Petersburg, FL 33702 Phone: 813-922-8809 | |
Dr. Samantha Turetsky, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 33 6th St S Ste 205, St Petersburg, FL 33701 Phone: 727-490-8811 |